World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
55
Citations
9923
World Ranking
3817
National Ranking
161

Overview

Michael P. Pender is affiliated with the University of Queensland in Australia. Their research focuses primarily on multiple sclerosis and related immunological and neurological disorders.

The scientist has published extensively in the field of medicine, with 29 publications attributed to this main discipline. Their work spans several subfields including pathology and forensic medicine, immunology, oncology, neurology, and rheumatology.

Key topics in their research include:

  • Multiple Sclerosis Research Studies
  • Polyomavirus and related diseases
  • Peripheral Neuropathies and Disorders
  • Systemic Lupus Erythematosus Research
  • T-cell and Retrovirus Studies
  • Galectins and Cancer Biology
  • Olfactory and Sensory Function Studies

Their recent papers cover significant aspects of multiple sclerosis, including clinical improvements with T cell therapy and immune response factors:

  • "Sustained Clinical Improvement in a Subset of Patients With Progressive Multiple Sclerosis Treated With Epstein-Barr Virus-Specific T Cell Therapy," 2021, Frontiers in Neurology
  • "Correlation Between Anti-Myelin Proteolipid Protein (PLP) Antibodies and Disease Severity in Multiple Sclerosis Patients With PLP Response-Permissive HLA Types," 2020, Frontiers in Immunology
  • "High Prudent diet factor score predicts lower relapse hazard in early multiple sclerosis," 2020, Multiple Sclerosis Journal
  • "Epstein-Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies," 2021, Trends in Molecular Medicine
  • "Epstein-Barr virus-specific T cell therapy for progressive multiple sclerosis," 2020, JCI Insight

Their frequent coauthors include Bruce Taylor, Alan Coulthard, Anne-Louise Ponsonby, Jeannette Lechner-Scott, and Simon Broadley.

Publication venues where their work appears regularly include Multiple Sclerosis Journal, Brain Communications, Journal of Neurology, Frontiers in Neurology, and Frontiers in Immunology.

Best Publications

  • Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20

    Melanie Bahlo;David R Booth;Simon A Broadley;Matthew A Brown;Matthew A Brown

  • Sun exposure and vitamin D are independent risk factors for CNS demyelination

    Robyn Lucas;A.-L. Ponsonby;K. Dear;P.C. Valery

  • Infection of autoreactive B lymphocytes with EBV, causing chronic autoimmune diseases.

    Michael P. Pender

  • Apoptosis in the nervous system in experimental allergic encephalomyelitis

    M.P. Pender;K.B. Nguyen;P.A. McCombe;J.F.R. Kerr

  • Epstein–Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies

    Amit Bar-Or;Michael P. Pender;Rajiv Khanna;Lawrence Steinman

  • CD8+ T-Cell Deficiency, Epstein-Barr Virus Infection, Vitamin D Deficiency, and Steps to Autoimmunity: A Unifying Hypothesis

    Michael P. Pender

  • Immunology of multiple sclerosis.

    Michael P. Pender;Judith M. Greer

  • Immune dysregulation and self-reactivity in schizophrenia: do some cases of schizophrenia have an autoimmune basis?

    Amanda L Jones;Bryan J Mowry;Michael P Pender;Michael P Pender;Judith M Greer

  • The Essential Role of Epstein-Barr Virus in the Pathogenesis of Multiple Sclerosis

    Michael P. Pender

  • Variation in the vitamin D receptor gene is associated with multiple sclerosis in an Australian population

    Lotfi Tajouri;Micky Ovcaric;Rob Curtain;Matthew Peter Johnson

  • Increased circulating antiganglioside antibodies in primary and secondary progressive multiple sclerosis

    B. Tayyebeh Sadatipour;Judith M. Greer;Michael P. Pender

  • Apoptosis of inflammatory cells in immune control of the nervous system: Role of glia

    Michael P. Pender;Michael J. Rist

  • Epstein-Barr virus and multiple sclerosis: potential opportunities for immunotherapy.

    Michael P Pender;Michael P Pender;Michael P Pender;Scott R Burrows;Scott R Burrows

  • Epstein-Barr virus–specific T cell therapy for progressive multiple sclerosis

    Michael P. Pender;Michael P. Pender;Michael P. Pender;Peter A. Csurhes;Corey Smith;Nanette L. Douglas;Nanette L. Douglas

  • Epstein–Barr virus and multiple sclerosis

    Robyn Lucas;Ann Maree Hughes;Meav-Lang Lay;Anne-Louise Ponsonby

  • Offspring number, pregnancy, and risk of a first clinical demyelinating event The AusImmune Study

    A.-L. Ponsonby;Robyn Lucas;I.A. Van Der Mei;K. Dear

  • Genetically determined failure of activation-induced apoptosis of autoreactive T cells as a cause of multiple sclerosis

    Michael P Pender

  • Apoptosis of αβ T Lymphocytes in the Nervous System in Experimental Autoimmune Encephalomyelitis: Its Possible Implications for Recovery and Acquired Tolerance

    Michael P. Pender;Pamela A. McCombe;Gerald Yoong;Kim B. Nguyen

  • Defective T-cell control of Epstein-Barr virus infection in multiple sclerosis.

    Michael P Pender;Peter A Csurhes;Jacqueline M Burrows;Scott R Burrows

  • The occurrence of autoimmune diseases in patients with multiple sclerosis and their families.

    Robert D. Henderson;Christopher J. Bain;Michael P. Pender

  • Variation in the vitamin D receptor gene is associated with multiple sclerosis in an Austrlaian population

    Lotti Tajouri;Micky Ovcaric;Rob Curtain;Matthew P. Johnson

Frequent Co-Authors

Anne-Louise Ponsonby
Anne-Louise Ponsonby University of Melbourne
Terence Dwyer
Terence Dwyer University of Oxford
Scott R. Burrows
Scott R. Burrows QIMR Berghofer Medical Research Institute
Lyn R. Griffiths
Lyn R. Griffiths Queensland University of Technology
Anthony J. McMichael
Anthony J. McMichael Australian National University
Rajiv Khanna
Rajiv Khanna QIMR Berghofer Medical Research Institute
Michael F. Good
Michael F. Good Griffith University
Helmut Butzkueven
Helmut Butzkueven Monash University
Matthew A. Brown
Matthew A. Brown Guy's and St Thomas' NHS Foundation Trust
Jason M. Mackenzie
Jason M. Mackenzie University of Melbourne

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare fields can open up diverse career opportunities. Many professionals pivot to nursing roles, which complement immunological expertise, especially in clinical research and patient care. Online accelerated nursing programs for non nurses provide a fast track into the nursing profession without prior healthcare experience, making it a popular option for career changers.

If admission competitiveness is a concern, students might consider the easiest accelerated nursing programs to get into. These programs balance accessibility with quality education, allowing students to begin their nursing careers sooner. Likewise, LPN schools easy to get into offer a great entry point into nursing, often serving as a stepping stone to advanced practice.

For those aiming higher, nurse practitioner roles merge clinical skills with advanced patient management. Identifying what is the easiest NP program can help prospective students choose a pathway that suits their schedule and career goals without compromising on credentials. Overall, these related degrees enhance career flexibility and growth in fields connected to immunology.

Learn more about online accelerated nursing programs for non nurses, explore the easiest accelerated nursing programs to get into, discover lpn schools easy to get into, and find out what is the easiest np program to suit your educational needs.

Best Scientists Citing Michael P. Pender

Trending Scientists